These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34592901)

  • 21. Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides.
    Egan JB; Shi CX; Tembe W; Christoforides A; Kurdoglu A; Sinari S; Middha S; Asmann Y; Schmidt J; Braggio E; Keats JJ; Fonseca R; Bergsagel PL; Craig DW; Carpten JD; Stewart AK
    Blood; 2012 Aug; 120(5):1060-6. PubMed ID: 22529291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patterns.
    Schinke C; Boyle EM; Ashby C; Wang Y; Lyzogubov V; Wardell C; Qu P; Hoering A; Deshpande S; Ryan K; Thanendrarajan S; Mohan M; Yarlagadda N; Khan M; Choudhury SR; Zangari M; van Rhee F; Davies F; Barlogie B; Morgan G; Walker BA
    Blood Cancer J; 2020 Jun; 10(6):70. PubMed ID: 32555163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global methylation patterns in primary plasma cell leukemia.
    Todoerti K; Calice G; Trino S; Simeon V; Lionetti M; Manzoni M; Fabris S; Barbieri M; Pompa A; Baldini L; Bollati V; Zoppoli P; Neri A; Musto P
    Leuk Res; 2018 Oct; 73():95-102. PubMed ID: 30257227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical Characteristics and Survival Analysis of Patients with Plasma Cell Leukemia].
    Wang SF; Qin XQ; Guo QH; Wang JY; Ma YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):693-698. PubMed ID: 37356928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles.
    Mosca L; Musto P; Todoerti K; Barbieri M; Agnelli L; Fabris S; Tuana G; Lionetti M; Bonaparte E; Sirchia SM; Grieco V; Bianchino G; D'Auria F; Statuto T; Mazzoccoli C; De Luca L; Petrucci MT; Morabito F; Offidani M; Di Raimondo F; Falcone A; Caravita T; Omedè P; Boccadoro M; Palumbo A; Neri A
    Am J Hematol; 2013 Jan; 88(1):16-23. PubMed ID: 23044976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma cell leukemia in North India: retrospective analysis of a distinct clinicohematological entity from a tertiary care center and review of literature.
    Bommannan K; Sachdeva MU; Malhotra P; Kumar N; Sharma P; Naseem S; Ahluwalia J; Das R; Varma N; Prakash G; Khadwal A; Srinivasan R; Varma S
    Blood Res; 2016 Mar; 51(1):23-30. PubMed ID: 27104188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis.
    Bezieau S; Devilder MC; Avet-Loiseau H; Mellerin MP; Puthier D; Pennarun E; Rapp MJ; Harousseau JL; Moisan JP; Bataille R
    Hum Mutat; 2001 Sep; 18(3):212-24. PubMed ID: 11524732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of ITGA6 confers to the invasion of multiple myeloma and promotes progression to plasma cell leukaemia.
    Song S; Zhang J; Su Q; Zhang W; Jiang Y; Fan G; Qian C; Li B; Zhuang W
    Br J Cancer; 2021 May; 124(11):1843-1853. PubMed ID: 33785876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary plasma cell leukemia presenting as a thoracic mass.
    Igala M; Bopaka RG; Khtabi W; Benchekroun S; Quessar A
    Pan Afr Med J; 2014; 19():39. PubMed ID: 25667701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomics of Plasma Cell Leukemia.
    Rojas EA; Gutiérrez NC
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of Circulating Plasma Cells on the Prognosis of Patients with Multiple Myeloma].
    Li F; Gao YJ; Li SS; Xi YY; Yang XW; Su YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1771-1779. PubMed ID: 38071059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis.
    Jimenez-Zepeda VH; Dominguez-Martinez VJ
    Int J Hematol; 2009 Apr; 89(3):259-268. PubMed ID: 19326058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary plasma cell leukemia: A report of two cases of a rare and aggressive variant of plasma cell myeloma with the review of literature.
    Gangadhar P; Ahmed Z; Pai MR; Sandhya I
    Indian J Pathol Microbiol; 2016; 59(4):541-544. PubMed ID: 27721294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation.
    Lionetti M; Barbieri M; Todoerti K; Agnelli L; Marzorati S; Fabris S; Ciceri G; Galletti S; Milesi G; Manzoni M; Mazzoni M; Greco A; Tonon G; Musto P; Baldini L; Neri A
    Oncotarget; 2015 Sep; 6(27):24205-17. PubMed ID: 26090869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia.
    Lionetti M; Musto P; Di Martino MT; Fabris S; Agnelli L; Todoerti K; Tuana G; Mosca L; Gallo Cantafio ME; Grieco V; Bianchino G; D'Auria F; Statuto T; Mazzoccoli C; De Luca L; Petrucci MT; Offidani M; Di Raimondo F; Falcone A; Caravita T; Omede' P; Morabito F; Tassone P; Boccadoro M; Palumbo A; Neri A
    Clin Cancer Res; 2013 Jun; 19(12):3130-42. PubMed ID: 23613318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols.
    Usmani SZ; Nair B; Qu P; Hansen E; Zhang Q; Petty N; Waheed S; Shaughnessy JD; Alsayed Y; Heuck CJ; van Rhee F; Milner T; Hoering A; Szymonifka J; Sexton R; Sawyer J; Singh Z; Crowley J; Barlogie B
    Leukemia; 2012 Nov; 26(11):2398-405. PubMed ID: 22508408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-exome sequencing of primary plasma cell leukemia discloses heterogeneous mutational patterns.
    Cifola I; Lionetti M; Pinatel E; Todoerti K; Mangano E; Pietrelli A; Fabris S; Mosca L; Simeon V; Petrucci MT; Morabito F; Offidani M; Di Raimondo F; Falcone A; Caravita T; Battaglia C; De Bellis G; Palumbo A; Musto P; Neri A
    Oncotarget; 2015 Jul; 6(19):17543-58. PubMed ID: 26046463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secondary plasma cell leukaemia (PCL) with plasmablastic morphology.
    Xu K; Nacheva E
    J Hematop; 2024 Jun; 17(2):117-119. PubMed ID: 38580782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired del(9)(p22.3) in a primary plasma cell leukemia.
    Achkar WA; Wafa A; Aljapawe A; Othman MA; Alhourani E; Liehr T
    Mol Cytogenet; 2013 Aug; 6(1):33. PubMed ID: 23985162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromosome studies in plasma cell leukemia and multiple myeloma in transformation.
    Jonveaux P; Berger R
    Genes Chromosomes Cancer; 1992 Jun; 4(4):321-5. PubMed ID: 1377939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.